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reward learning were observed in animals with reduced ASM 
function. Importantly, free-choice alcohol drinking—but not 
forced alcohol exposure—reduces depression-like behavior 
selectively in depressed animals through the normalization 
of brain ASM activity. No such effects were observed in nor-
mal mice. ASM hyperactivity caused sphingolipid and sub-
sequent monoamine transmitter hypo-activity in the brain. 
Free-choice alcohol drinking restores nucleus accumbens 
sphingolipid- and monoamine homeostasis selectively in 
depressed mice. A gene expression analysis suggested strong 
control of ASM on the expression of genes related to the reg-
ulation of pH, ion transmembrane transport, behavioral fear 
response, neuroprotection and neuropeptide signaling path-
ways. These findings suggest that the paradoxical antidepres-
sant effects of alcohol in depressed organisms are mediated 
by ASM and its control of sphingolipid homeostasis. Both 
emerge as a new treatment target specifically for depression-
induced alcoholism.
Abstract Alcohol is a widely consumed drug that can lead 
to addiction and severe brain damage. However, alcohol is 
also used as self-medication for psychiatric problems, such 
as depression, frequently resulting in depression-alcoholism 
comorbidity. Here, we identify the first molecular mecha-
nism for alcohol use with the goal to self-medicate and ame-
liorate the behavioral symptoms of a genetically induced 
innate depression. An induced over-expression of acid sphin-
gomyelinase (ASM), as was observed in depressed patients, 
enhanced the consumption of alcohol in a mouse model of 
depression. ASM hyperactivity facilitates the establishment 
of the conditioned behavioral effects of alcohol, and thus 
drug memories. Opposite effects on drinking and alcohol 
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Introduction
Alcohol is a major psychoactive drug in western societies 
[24]. The majority of adults regularly consume alcohol 
with the risk of developing an alcohol use disorder (AUD) 
[13, 63], accompanied by severe brain pathologies [68]. It 
was shown that alcohol can be instrumentalized, i.e., used 
to achieve goals that would be impossible to achieve or that 
require a greater workload without alcohol use [47, 48]. 
Alcohol use can serve numerous instrumentalization goals, 
such as the facilitation of social interaction, mating behav-
ior, or stress coping. One of the most important goals is the 
self-medication for innate or induced psychiatric problems, 
such as for depression and/or anxiety disorders [5, 47, 54]. 
There is a high comorbidity of depression and alcohol use 
disorder with bi-directional trajectories [55]. Depression 
can either be induced after an AUD has manifested, or a 
depression emerges first and alcohol is used subsequently 
to ameliorate the symptoms of depression [19, 64]. While 
the neuropharmacology of alcohol is well known [17, 73], 
the neurobiological mechanisms for the potential antide-
pressant effects of alcohol and their instrumentalization 
remain poorly understood [34].
Together with cholesterol and glycerophospholipids, 
sphingolipids are the most common lipids in brain mem-
branes [30]. Sphingolipids form lipid rafts and signaling plat-
forms, which are membrane compartments that are enriched 
in G-protein-coupled receptors [20, 72]. Changes in the com-
position of the lipid rafts and platforms directly affect recep-
tor affinity, signaling and subsequent internalization [14, 20]. 
Acid sphingomyelinase (ASM) hydrolyses sphingomyelin 
(SM) to ceramide (Cer) and phosphorylcholine, and thus rep-
resents a major regulator of sphingolipid metabolism [31]. 
Sphingolipids are involved in fundamental cellular processes, 
such as differentiation, senescence, and apoptosis [22], as 
well as in behavioral adaptations [29, 53] and psychiatric 
disorders [51, 65]. It was shown that depressed patients and 
alcohol dependent patients during withdrawal show increased 
ASM activity in peripheral blood mononucleated cells and 
in the plasma [36, 58, 59]. Transgenic mice over-expressing 
ASM (tgASM) display a reduced neurogenesis in the hip-
pocampus and a depression/anxiety phenotype, which can be 
reversed by the functional inhibitors of ASM [21, 38].
Here, we identify a new molecular mechanism for the 
paradoxical antidepressant effects of alcohol when used 
voluntarily to self-medicate and ameliorate the behav-
ioral symptoms of a genetically induced depression. We 
show that alcohol drinking normalizes ASM function and 
re-establishes sphingolipid- and monoamine homeostasis 
in the nucleus accumbens of depressed mice. Thus, sphin-
golipid homeostasis emerges as a new mechanism to con-
trol depression-AUD comorbidity.
Materials and methods
Animals
In ASM transgenic mice (tgASM), the murine Smpd1 
cDNA was expressed under the control of the ubiquitous 
CAG promoter. A loxP-flanked STOP cassette was included 
between the promoter and the transgene so that the expres-
sion can be conditionally regulated by the action of Cre 
recombinase. The conditional transgene was introduced 
into the deleted Hprt gene locus of E14 embryonic stem 
cells. The transgenic mice were generated and back-crossed 
for at least 5 generations to C57BL/6 mice. The transgene 
was constitutively expressed by crossing the mice with 
E2A-Cre mice expressing Cre recombinase under the con-
trol of an E2A promoter with a C57BL/6 background [21]. 
The WT mice used in this study were floxed Cre-positive 
mice without the ASM transgene. Heterozygous ASM-defi-
cient mice (Smpd1+/−, hetKO ASM) [27] were originally 
obtained from Dr. R. Kolesnick, Memorial Sloan-Ketter-
ing Cancer Center, New York, NY, USA. Male and female 
tgASM and hetKO ASM and respective wild type (WT) 
mice (8–12 weeks old) were studied in gender balanced 
designs. All experiments were carried out in accordance 
with the National Institutes of Health guidelines for the 
humane treatment of animals and the European Communi-
ties Council Directive (86/609/EEC), and were approved 
by the local governmental commission for animal health.
Alcohol drinking and alcohol deprivation effect
Alcohol drinking was tested in naïve tgASM, hetKO ASM 
and respective WT mice using a two-bottle free-choice 
drinking paradigm. Mice were single housed and each 
cage was equipped with two bottles that were constantly 
available, one of which contained tap water and the other 
bottle contained alcohol at various concentrations. After 
an acclimatization period of two weeks to establish a 
drinking baseline, the animals received alcohol at increas-
ing concentrations of 2, 4, 8, 12, and 16 vol% for 4 days 
each. Thereafter, the alcohol concentration was main-
tained at 16 vol% for 12–14 days. To measure the alco-
hol deprivation effect, alcohol was removed for 3 weeks 
(with both bottles containing tap water) before it was re-
introduced for 4 days. This procedure was repeated one 
(hetKO ASM) or two (tgASM) more times. The bottles 
were changed and weighed daily. The consumed amount 
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of alcohol relative to body weight and preference vs. 
water were measured [11, 69].
Taste preference test
Alcohol-experienced animals (42 free-choice drinking 
days) were used for this test. Sucrose (0.5 and 5%) and 
quinine (2 and 20 mg/dl) preferences were measured in a 
two-bottle free-choice test vs. water three days after the last 
alcohol exposure. Each dose was offered for 3 days with 
the position of the bottles being changed and weighed daily 
with a 1-day wash out between the sucrose and quinine 
testing [11, 69].
Conditioned place preference
The establishment of alcohol-induced conditioned place 
preference (CPP) was tested in naïve tgASM, hetKO ASM 
and respective WT mice with a time-course CPP model 
described previously [12]. Subsequently, food-induced 
CPP was tested in naïve tgASM and WT mice following 
the same procedure. The week before testing, the animals 
were accustomed to food pellets (45 mg sucrose pellets) 
with five pellets/day. Before each conditioning trial, ani-
mals were food deprived for 24 h. During conditioning, 
they received 20 pellets during the 30 min conditioning 
trials, or no food during pseudo-conditioning trials. After 
each learning trial, they received free access to food for 2 h 
in their home cages (see Supplementary Information (SI)).
Loss of righting reflex
Alcohol-naïve animals were administered with 3.5 g/kg (i.p.) 
alcohol in saline (vinj = 20 ml/kg) to induce a loss of the 
righting reflex (LORR), and were immediately placed in an 
empty cage. LORR was observed when the animal becomes 
ataxic and stopped moving for at least 30 s. The animal was 
then placed on its back. Recovery from alcohol administra-
tion was defined as the animal being able to right itself three 
times within a minute. A 2 h cut off was used. The time 
taken for the animal to lose its righting reflex and the time to 
recovery from the alcohol’s effects were recorded [11, 75].
Blood alcohol determination
Alcohol naïve animals received an alcohol injection (3.0 g/
kg, i.p.) and 20 µl blood samples were obtained from 
the submandibular vein 1, 2, and 3 h after injection. The 
blood samples were directly mixed with 80 µl 6.25% (w/v) 
trichloroacetic acid. After centrifugation, 15 µl of the super-
natant were subjected to enzymatic alcohol determination 
using the alcohol dehydrogenase method as described else-
where [56, 75].
Emotional behavior after alcohol exposure
Free‑choice consumption
Alcohol drinking was established in naïve tgASM and WT 
mice using a two-bottle free-choice drinking paradigm as 
described above but with bottle measurements every sec-
ond day [9, 60]. After 12 days of drinking 16 vol% alco-
hol, the animals were tested with a battery of behavioral 
tests including open field, elevated plus maze, novelty sup-
pressed feeding, and the forced swim test, as described pre-
viously [10, 70] (see SI). They continued drinking alcohol 
in their home cages throughout the testing.
Forced alcohol exposure
Naïve tgASM or hetKO ASM and respective WT mice 
received an injection with alcohol (2 g/kg; i.p.) or saline 
30 min before each behavioral test (total: 5 injections). 
Behavioral tests were then performed as described above 
[10, 70] (see SI). The mice were tested in a pseudorandom 
order and were moved to the behavioral suite adjacent to the 
housing room 1 h before testing. The mice were returned to 
their home cages at the end of each test and were allowed 
at least 2 days to recover before further testing [10, 70]. 
After the behavioral testing commenced the animals were 
sacrificed, after which blood was collected and brain tissue 
was harvested for an analysis of ASM activity.
Acid sphingomyelinase activity
Acid sphingomyelinase activity was measured in the dor-
sal hippocampus and serum of either free-choice alcohol 
drinking or forced alcohol exposure-treated tgASM, hetKO 
ASM, or respective WT mice using the fluorescent sub-
strate BODIPY-FL-C12-SM (N-(4,4-difluoro-5,7-dimethyl-
4-bora-3a,4a-diaza-s-indacene-3-dodecanoyl) sphingosyl 
phosphocholine, D-7711, Invitrogen/Life Technologies) 
method, with three replicates for each sample as described 
previously [29] (see SI).
MALDI imaging mass spectrometry
tgASM and WT mice were trained to drink 16 vol% alco-
hol in a two-bottle free-choice drinking procedure as 
described above. The control groups received water in 
both bottles the entire time. Immediately after a 20 day 
reinstatement of 16 vol% alcohol drinking, the animals 
were sacrificed, after which the brains were harvested 
and snap-frozen with dry ice and then stored at −80 °C. 
For MALDI Imaging MS, coronal brain slices were pre-
pared at the level of either the nucleus accumbens (Nac; 
area of interest 1) or the dorsal hippocampus (DH; area 
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of interest 2). All slides were prepared using the Image-
Prep (Bruker Daltonik GmbH, Bremen) using α-cyano-
4-hydroxycinnamic acid as the matrix and the standard 
method for this matrix for the preparation device. For 
MALDI-MS measurements, the prepared slides were 
mounted onto a Slide Adapter (Bruker Daltonik GmbH, 
Bremen) and loaded into the dual source of a 12T FTICR 
MS (SolariX XR, Bruker Daltonics). The data were 
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analyzed using FlexImaging (4.1), and DataAnalysis (4.2) 
(both Bruker Daltonik GmbH) [66] (see SI).
Post mortem neurochemistry
For an estimation of the brain tissue monoamine levels, 
tgASM and WT mice were investigated after free-choice 
alcohol consumption and emotional behavior testing. One 
day after behavioral testing and immediately after continued 
free-choice 16 vol% alcohol consumption, the mice were 
sacrificed and decapitated, and the brains were harvested 
and snap frozen with CO2. For the neurochemical analysis, 
the brain areas were dissected: ventral striatum, dorsal hip-
pocampus, and prefrontal cortex. The tissue was homog-
enized in 0.5 M perchloric acid, it was then centrifuged, fil-
tered, and stored at −80 °C until an analysis of monoamine 
content was done, as previously described [52, 57] (see SI).
RNA‑seq analysis, co‑expression network analysis 
and module characterization
tgASM and WT mice, which had been either drinking 
16 vol% alcohol or water as described above, were tested for 
mRNA expression in the DH using RNA-seq. Immediately 
after a 20 day reinstatement of 16 vol% alcohol drinking, the 
mice were sacrificed by cervical dislocation, and brains were 
harvested and snap frozen on dry ice. The areas of interest 
were cut from coronal sections of 1-mm thickness accord-
ing to the anatomical coordinates taken from the Franklin 
& Paxinos [15] mouse brain atlas. The total RNA was iso-
lated with an RNeasy Mini Kit (Qiagen, Hilden, Germany) 
according to the manufacturers’ instructions (see SI).
Before and during the library preparation, the RNA 
quality was ascertained using a 2100 Bioanalyzer sys-
tem (Agilent Technologies). Barcoded and strand-specific 
whole transcriptome sequencing libraries were prepared 
from 100 ng of DNase digested total RNA using an Ova-
tion Human FFPE RNA-seq System (NuGEN) accord-
ing to the manufacturer’s instructions. The human rRNA 
was depleted using human specific NuGEN InDA-C oli-
gonucleotides. The pooled libraries were sequenced on 
a HiSeq 2500 platform (Illumina) generating 82 million 
101 bp single-end reads on average.
After alignment against the reference genome GRCm38 
using STAR v.2.4.0i [7], the absolute read counts for all 
Ensembl genes (version 75) were determined with HTSeq 
count v.0.6.1. [1]. A differential expression analysis 
accounting for the paired design with respect to the pri-
mary cell cultures was performed using the DESeq 2 pack-
age v.1.10.1. [9, 43]. The p values were corrected using the 
false discovery rate method.
A network analysis was performed with the R package 
weighted gene co-expression networks (WGCNA) on nor-
malized and transformed data obtained from the RNA-seq. 
Genes with excessive zero counts (80% of total sample) 
were removed, and the genes with a variance above the 
median variance were retained for the network analysis. We 
used a robust correlation measure bicor to create a correla-
tion matrix containing all pair-wise correlations between all 
genes across all samples (see SI).
Superoxide dismutase protein expression
The effects of free-choice 16 vol% alcohol drinking and 
abstinence after drinking on superoxide dismutase (SOD) 
activity and SOD1 and SOD2 protein expression in the cer-
ebellum of the tgASM and WT mice were analyzed as pre-
viously described [67] (see SI). The cerebellum was chosen 
as an exploratory target for the SOD assay due to its high 
sensitivity to the toxic morphological effects of alcohol 
Fig. 1  Alcohol consumption is enhanced in mice overexpress-
ing acid sphingomyelinase (tgASM) and is reduced in mice with 
acid sphingomyelinase deficiency (heterozygous ASM knock out—
hetKO ASM). The error bars show the mean ± SEM. a, b Alcohol 
consumption and preference vs. water are enhanced in tgASM mice 
at different doses of alcohol in a two-bottle free-choice drinking 
paradigm (n = 16/group). A two-way ANOVA for alcohol consump-
tion showed a significant effect for the genotype (F1,150 = 51.737, 
p < 0.001) and dose (F4,150 = 13.438, p < 0.001) but showed no 
interaction. A two-way ANOVA for alcohol preference showed 
a significant effect for the genotype (F1,150 = 4.40, p = 0.037) and 
dose (F4,150 = 1002.19, p < 0.001) but no interaction (*p < 0.05, 
**p < 0.01, ***p < 0.001 vs. wild type; WT). c, d Alcohol preference 
vs. water—but not total consumption—is attenuated in hetKO ASM 
mice at different doses of alcohol in a two-bottle free-choice drinking 
paradigm (n = 12–15/group). A two-way ANOVA for alcohol pref-
erence showed a significant effect for the genotype (F1,120 = 9.846, 
p = 0.002) and dose (F4,120 = 18.488, p < 0.001) but no interaction 
(*p < 0.05, vs. WT). e tgASM mice show persistent high consump-
tion of a 16 vol% alcohol solution (n = 16/group). Three-week with-
drawal periods (dashed green lines) repeatedly induced an alcohol 
deprivation effect (ADE). This effect was significantly enhanced in 
tgASM mice, suggesting potentiated susceptibility to alcohol with-
drawal effects on drinking motivation. A two-way ANOVA for the 
ADE showed a significant effect for the genotype (F1,30 = 324.621, 
p < 0.001) and days (F25,750 = 37.438, p < 0.001) and a geno-
type × test day interaction (F25,750 = 33.763, p < 0.001) (*p < 0.05, 
$p < 0.01, #p < 0.001 vs. day 14—last day before withdrawal). f Two 
three-week withdrawal periods (dashed green lines) further reduced 
alcohol drinking in hetKO ASM mice (n = 12–14/group). A two-way 
ANOVA showed a significant effect for genotype (F1,528 = 6.535, 
p = 0.011) and days (F21,528 = 25.354, p < 0.001) but no interaction 
(*p < 0.05, $p < 0.01, #p < 0.001 vs. day 14—last day before with-
drawal). g tgASM mice show no difference in preference for sweet-
ness (sucrose) or avoidance of the low dose bitter solution (quinine) 
(n = 16/group). However, the avoidance of a high dose bitter solu-
tion was attenuated (genotype: F1,90 = 8.472, p = 0.004). h hetKO 
ASM mice show no difference in preference for sweet substances 
compared to WT (n = 12–14/group). However, hetKO ASM mice 
show a stronger avoidance of the bitter taste at 2 mg/dl (genotype: 
F1,72 = 4.192, p = 0.044) and 20 mg/dl quinine solution (genotype: 
F1,72 = 5.201, p = 0.026)
◂
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[16] mediated at least in part by oxidative stress [32], the 
involvement of the cerebellum in depression and addiction 
[46], and the high correlation of ASM activity between the 
dorsal hippocampus and cerebellum [29].
Statistics
All quantitative data were expressed as mean ± SEM. The 
data were analyzed using ANOVAs (for repeated measures 
where appropriate) followed by pre-planned comparisons 
using Fisher’s LSD tests with Bonferroni-correction or by 
post hoc Newman–Keuls’ test when appropriate. For sin-
gle group comparisons of normally distributed data, t tests 
were used. Although sex differences are well known in 
alcoholism-related behaviors [42], we did not see signifi-
cant sex differences in the major parameters of this study 
(Suppl. Tab. 1). Therefore, the data were collapsed for anal-
ysis. A significance level of p < 0.05 was used.
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Results
Enhanced alcohol consumption in mice with ASM 
hyperactivity
We have previously shown that the overexpression of ASM 
and the resulting increase in Cer inhibit neurogenesis in 
the hippocampus and induce depression-like behavior in 
mice [21]. Here, we report that tgASM mice drink signifi-
cantly more alcohol in a two-bottle free-choice paradigm 
than wild type (WT) controls (Fig. 1a). They also show a 
small enhancement in the alcohol preference vs. water at 
the genotype level which, however, reached significance 
only at the ANOVA level (factor genotype: F1,150 = 4.40, 
p = 0.038; Fig. 1b). Water consumption alone was not dif-
ferent in tgASM and WT mice when they had only water 
available (Suppl. Figure 1). To test alcohol consumption in 
animals with reduced ASM activity, we used heterozygous 
ASM knock-out mice (hetKO ASM). Homozygous ASM 
KO mice develop neurodegeneration similar to Niemann–
Pick disease after only a few month of age [4, 40], while 
hetKO ASM mice show no such symptoms. In hetKO ASM 
mice, the total amount of consumed alcohol did not signifi-
cantly change (Fig. 1c). Alcohol preference vs. water, in 
contrast, showed a significant decline vs. WT but only at a 
medium concentration of 4–8 vol% alcohol (Fig. 1d).
In tgASM mice, enhanced consumption of 16 vol% 
alcohol was preserved over time. Repeated withdrawal 
from alcohol for three weeks and subsequent reinstate-
ment induced an alcohol deprivation effect (ADE) in WT 
mice. This effect was significantly potentiated in tgASM 
mice after the first, second, and third withdrawal (Fig. 1e). 
HetKO ASM mice, however, maintained their alcohol con-
sumption over time. The withdrawal and reinstatement 
of alcohol drinking resulted in a significant decline in the 
amount of alcohol consumed (Fig. 1f). Neither tgASM nor 
hetKO ASM mice showed an altered preference for sweet-
ness (Fig. 1g, h). However, tgASM mice showed a signifi-
cantly reduced avoidance of a strong bitter tasting quinine 
solution at a dose of 20 mg/dl, while bitter taste avoid-
ance was enhanced in hetKO ASM mice at 2 and 20 mg/
dl solutions. Overall, the marginally altered sensitivity to 
bitterness cannot explain the strong alcohol preference of 
tgASM mice or the attenuated preference in hetKO ASM 
mice. Altogether, these findings suggest that ASM hyper-
function results not only in a depression-like phenotype 
[21] but also in a much enhanced consumption of alcohol 
and potentiated sensitivity for the reinstatement of drinking 
after withdrawal.
Accelerated onset of conditioned alcohol effects in mice 
with ASM hyperactivity
The establishment of controlled drug use for drug instrumen-
talization requires distinct drug memories [47, 49, 61]. To 
test the role of ASM in drug memories we measured the time 
course for the establishment of conditioned reinforcing and 
conditioned locomotor effects and locomotor sensitization 
[11, 12]. We found that tgASM mice show a faster estab-
lishment of conditioned place preference (CPP) compared 
to WT controls (Fig. 2a). A significant CPP was observed 
in tgASM mice following only a single conditioning trial 
with alcohol. The repeated pairing of a spatial context with 
alcohol induced a conditioned hyperlocomotion in mice 
(Fig. 2b). This behavior was also established more quickly 
in tgASM mice than in WT mice, i.e., after only 3 condition-
ing trials at T2. The locomotor effects of an acute alcohol 
injection (2 g/kg, i.p.) did not differ between tgASM and 
WT mice. Repeated alcohol injections (2 g/kg, i.p.) had no 
significant effect on locomotor activity compared to the first 
Fig. 2  Acid sphingomyelinase (ASM) facilitates the establish-
ment of alcohol-conditioned behavioral effects. The error bars 
show the mean ± SEM. a A conditioned place preference (CPP) is 
established after a repeated conditioning with alcohol (2 g/kg, i.p.; 
ANOVA, factor time: F3,78 = 5.676, p = 0.001). However, the alco-
hol CPP is established more quickly in mice overexpressing ASM 
(tgASM, n = 13) than in wild type (WT, n = 15) mice. The animals 
were tested for time spent in the alcohol paired compartment dur-
ing the baseline (Bl) and after one (T1), three (T2) and seven (T3) 
conditioning sessions with alcohol (*p < 0.05, **p < 0.01, vs. Bl). 
b Conditioned hyperactivity is expressed during CPP test trials 
(ANOVA, factor time: F3,78 = 9.027, p < 0.001). Conditioned hyper-
activity emerged faster in tgASM (n = 13) than in WT (n = 15) 
mice (*p < 0.05, ***p < 0.001 vs. Bl). c There was no difference in 
the acute locomotor response to alcohol between tgASM and WT 
mice. The acute locomotor effects changed with repeated injections 
(ANOVA, factor time: F6,156 = 2.459, p = 0.027). While there was a 
decline in locomotor responding after repeated alcohol injections in 
WT mice (n = 15), tgASM mice (n = 13) showed a significant sen-
sitization (*p < 0.05 vs. BL; #p < 0.05 vs. WT). d Alcohol CPP is not 
established in mice with ASM hypoactivity (hetKO ASM; n = 14) 
but was established in WT mice (n = 14; ANOVA, time × genotype 
interaction: F3,72 = 3.575, p = 0.018). The animals were tested for 
the time spent in the alcohol-paired compartment during the baseline 
and after one (T1), three (T2) and seven (T3) conditioning sessions 
with alcohol (2 g/kg, i.p.; *p < 0.05 vs. BL; #p < 0.05 vs. WT). e Con-
ditioned hyperactivity is expressed during CPP test trials (ANOVA, 
factor time: F3,72 = 5.074, p = 0.003) to a similar degree in WT 
(n = 12) and hetKO ASM mice (n = 14; (*p < 0.05, **p < 0.01 vs. 
Bl). f There was no difference in the acute locomotor response to 
alcohol between hetKO ASM (n = 14) and WT mice (n = 12) dur-
ing the first conditioning trial. Acute locomotor effects changed with 
repeated injections (ANOVA, factor time: F6,144 = 3.936, p = 0.001). 
While there was a significant sensitization after repeated injection in 
WT mice, there was no sensitization effect observed in hetKO ASM 
mice (ANOVA, factor genotype: F1,24 = 5.105, p = 0.033; *p < 0.05, 
**p < 0.01, ***p < 0.001 vs. BL; #p < 0.05, §p < 0.01 vs. WT)). No 
effect of ASM hyperactivity (g, h) n = 8–11/group) or hypoactivity 
(j, k) (n = 6–16) on the sedating effect of alcohol (3.5 g/kg, i.p.), 
measured by the loss of righting reflex (LORR), was seen. (i, l) No 
effect of ASM hyperactivity (n = 8/group) or hypoactivity (n = 6–10/
group) on alcohol bioavailability, as shown in the blood alcohol con-
centration after an i.p. injection of alcohol (3 g/kg, i.p.), was seen
◂
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administration in WT mice. In tgASM mice, however, there 
was a significant sensitization of locomotor activity (Fig. 2c). 
Alcohol is a pharmacological reinforcer [68]. To test whether 
ASM hyperactivity would specifically facilitate the reinforc-
ing action of alcohol or that of all reinforcers, we measured 
the time course of food CPP establishment in tgASM mice. 
Repeated food delivery induced a significant preference for 
the food-paired compartment and conditioned hyperlocomo-
tion in this compartment. However, there was no difference 
between tgASM and WT mice (Suppl. Figure 2).
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While a significant CPP was established after seven alco-
hol conditioning trials in WT mice, reduced ASM activity 
prevented the establishment of an alcohol CPP completely 
(Fig. 2d). However, not all conditioned alcohol effects were 
absent in hetKO ASM mice. Conditioned hyperlocomo-
tion was established in WT and hetKO ASM mice at com-
parable speeds (Fig. 2e). Locomotor activity after an acute 
alcohol injection (2 g/kg, i.p.) did not differ between hetKO 
ASM and WT mice (Fig. 2f). While the locomotor response 
to an alcohol challenge (2 g/kg; i.p.) sensitized after seven 
treatments in WT mice, there was no sensitization in hetKO 
ASM mice. Taken together, these findings suggest that 
ASM hyperactivity facilitates the establishment of the con-
ditioned reinforcing-, conditioned locomotor- and locomo-
tor sensitization effects of repeated alcohol treatment [28, 
29]. From this, ASM emerges as a specific facilitator of the 
reinforcing effects of alcohol.
ASM activity does not control alcohol’s sedating effects 
or bioavailability
In depressed people, alcohol may be consumed to reach a 
level of sedation that attenuates rumination and perception 
of a negative emotional state. We, therefore, tested whether 
ASM plays a role in the sedating effects of alcohol using 
the LORR test. We found that neither ASM hyperactivity 
in tgASM mice nor the ASM hypofunction in hetKO ASM 
mice altered the sedating effects of alcohol measured in the 
time to achieve sedation and in the duration of the sedation 
after a single injection with 3.5 g/kg (i.p.) alcohol (Fig. 2g, 
h, j, k). Neither the ASM hyperactivity nor hypoactivity 
altered the bioavailability of alcohol in mice (Fig. 2i, l).
Free‑choice alcohol drinking restores ASM homeostasis 
and reverses depression‑like behavior in tgASM mice
We found that enhanced ASM activity in mice led to 
depression [21] and enhanced alcohol consumption. How-
ever, this could be due to ASM being a common underly-
ing factor for depression and alcohol drinking or a depres-
sion-AUD causality [6]. Hence, we asked whether alcohol 
consumption could reverse the depression-like phenotype 
and, therefore, serve as a self-medication. We tested naïve 
tgASM mice after establishing stable 16 vol% alcohol 
consumption in a two-bottle free-choice drinking test or 
after water drinking for their emotional phenotype. In this 
experiment, we replicated the enhanced alcohol consump-
tion in tgASM compared to WT mice (Fig. 3a). We found 
that free-choice alcohol drinking significantly reduced the 
latency to eat in the novelty suppressed feeding test only 
in tgASM mice but not in WT mice (Fig. 3b). Additionally, 
in the forced swim test, alcohol had antidepressant effects 
only in tgASM but not in WT mice by reducing the time of 
floating (Fig. 3c). A correlation analysis revealed that the 
higher the amount of alcohol consumed by the tgASM mice 
was, the stronger the reduction was in floating behavior in 
this test (Pearson, r = −0.642, p = 0.01). No such correla-
tion was found for WT mice (r = −0.139; p = 0.62; Suppl. 
Figure 3). In the open field, alcohol drinking enhanced the 
time spent in the center (Fig. 3d) and the locomotion in the 
center (Fig. 3e) only in tgASM mice. Alcohol drinking had 
no significant effect on total locomotion in the open field 
(p > 0.05), which suggests that the alcohol effects are not 
simply stimulant effects. Anxiety and depression are highly 
comorbid disorders but may be differentially regulated by 
sphingolipid systems [21, 51]. In this experiment, free-
choice alcohol drinking enhanced anxiety levels in tgASM 
mice, as shown by an increase in the latency to enter the 
open arms (Fig. 3f) and a decline in the time spent on the 
open arms (Fig. 3g). In contrast, alcohol drinking slightly 
reduced anxiety in WT mice indicated by an increase of 
open arm entries (Fig. 3h). It is unlikely that the anxiety 
induced in tgASM mice is due to withdrawal effects [41] 
since the animals were tested with alcohol that was avail-
able before and after testing. Additionally, the alcohol 
drinking did not yield a gross locomotor phenotype, which 
could have explained the antidepressant or anxiogenic 
effects of the alcohol drinking in the tgASM mice [44]. To 
test how alcohol drinking would affect ASM activity, we 
measured ASM mediated SM-Cer turnover in the dorsal 
hippocampus after free-choice alcohol drinking. Enhanced 
Fig. 3  Free-choice alcohol drinking reduces depression-like behavior 
selectively in depressed mice. The error bars show the mean ± SEM. 
a Preference vs. water and absolute consumption of 16 vol% alcohol 
in mice over-expressing acid sphingomyelinase (tgASM, n = 16) and 
wild type (WT, n = 16) mice in a two-bottle free-choice drinking test. 
The animals were trained for consumption with increasing doses of 
alcohol and then remained on a 16 vol% solution during testing. The 
values present an average consumption of 4 days. There was a signifi-
cant difference in preference at the target concentration of 16 vol% 
alcohol (t = −1.953; p = 0.03) and a trend for absolute consumption 
(t = −1.489, p = 0.07). b Alcohol drinking reduces depression-like 
behavior in the novelty suppressed feeding test selectively in tgASM 
mice (t = 2.305, p = 0.016; n = 13–16/group). c Alcohol drinking 
reduces depression-like behavior in the forced swim test selectively in 
tgASM mice (t = 1.878, p = 0.037). d, e The open field test showed 
a selective and temporally restricted anxiolytic-like effect of free-
choice alcohol drinking in tgASM mice, which is only indicated by 
an increase in center time (t = −1.922, p = 0.047) and locomotion in 
the center of the maze (t = −2.516, p = 0.0135) in the first 5 min of 
testing. f–h In the elevated plus maze test for anxiety alcohol drink-
ing enhanced anxiety-like behavior in tgASM mice, which is shown 
by prolonged latency to enter the open arms (t = −2.013, p = 0.027) 
and enhanced open arm time (t = 1.785, p = 0.044). In WT mice, 
alcohol drinking had a mild anxiolytic effect that was indicated by an 
increase in the number of open arm entries (t = −1.685, p = 0.05). i 
The ASM activity in the dorsal hippocampus was enhanced in tgASM 
mice compared to WT (n = 13–16/group; t = −3.918, p = 0.001). 
Free-choice alcohol drinking attenuated ASM activity in tgASM mice 
(t = 21.787, p = 0.047) (*p < 0.05, **p ≤ 0.01; ***p ≤ 0.001)
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ASM activity and subsequently increased ceramide levels 
in the dorsal hippocampus can induce depression in mice 
by inhibiting hippocampal neurogenesis [21]. In contrast, 
the dynamic down-regulation of dorsal hippocampus ASM 
activity was shown to predict re-learning during the extinc-
tion of an operant task [29]. Water-drinking tgASM mice 
showed ASM hyperactivity. Alcohol drinking had no effect 
on ASM activity in WT mice but instead normalized it 
in tgASM mice (Fig. 3i). ASM activity in the serum was 
enhanced in tgASM mice but was not affected by alcohol 
consumption (Suppl. Figure 4), thus suggesting that serum 
ASM is not a valid marker for the anti-depressant action of 
alcohol in the brains of depressed animals. Taken together, 
these findings suggest that free-choice alcohol drinking 
reduces depression-like behavior selectively in depressed 
animals but enhances anxiety levels. The anti-depressant 
effect of alcohol may be mediated by the normalization of 
ASM activity.
No antidepressant effects from forced alcohol exposure
It was suggested that the instrumentalization of alcohol 
as self-medication for depression requires individual self-
titration and control over intake [47, 48]. Therefore, we 
asked whether the pharmacological reinforcing and mild 
euphoria-inducing action of alcohol [68] would suffice to 
exert the antidepressant and ASM normalizing effects. The 
animals were submitted to a forced alcohol exposure by 
receiving injections with either saline or alcohol (2 g/kg; 
i.p), which has been shown to induce reinforcing effects in 
the CPP tests. During this exposition, we tested their emo-
tional behavior. In contrast to free-choice alcohol drinking, 
repeated forced exposure had no effects on the emotional 
behavior of the tgASM or WT mice in the novelty sup-
pressed feeding- and open field test (Fig. 4a, c, d). In the 
forced swim test, forced alcohol exposure enhanced the 
floating time in WT and tgASM mice to a similar extent, 
which is suggestive of an increase in depression-like behav-
ior (Fig. 4b). Interestingly, forced alcohol exposure also 
had the opposite effects on anxiety-related behavior com-
pared to free-choice alcohol drinking. Alcohol injections 
had an unspecific anxiolytic effect in tgASM and WT mice, 
indicated by an increase in the time spent on the open arms 
and the number of entries while not significantly affecting 
the latency of entries to open arms (Fig. 4e–g). In contrast 
to free choice alcohol drinking, forced alcohol exposure did 
not reverse the enhanced ASM activity in the DH of tgASM 
mice (Fig. 4h).
We also tested hetKO ASM mice for the effects of 
repeated forced alcohol exposure on emotional behavior. 
Mice with innate attenuation of ASM activity showed less 
depression-like behavior and reduced anxiety in some, but 
not all tests (Suppl. Figure 5) [21]. Repeated forced alcohol 
exposure (2 g/kg; i.p.) had no significant effect in WT mice 
but it enhanced depression-like behavior in the novelty sup-
pressed feeding- and forced swim test in hetKO ASM mice. 
Forced alcohol exposure also enhanced anxiety-like behav-
ior in the elevated plus maze test in hetKO ASM mice but 
had no effect on ASM activity in the DH (Suppl. Figure 5).
Altogether, these findings suggest that the pharmacolog-
ical and positively reinforcing action of alcohol is not suffi-
cient to attenuate depression in depressed individuals, pos-
sibly because it fails to normalize enhanced ASM activity. 
These findings favor an interpretation that the self-titration 
of the pharmacological action of alcohol is essential for its 
instrumentalization as self-medication for depression.
Alcohol drinking partially restores sphingomyelin 
levels in the nucleus accumbens but not in the dorsal 
hippocampus
ASM hyperactivity can induce depression by inducing a 
permanent sphingolipid allostasis in the brain. Many anti-
depressant drugs work, in addition to their action on mono-
amine systems, by exerting a functional inhibition of ASM 
[37, 38, 51]. Here, we explored how free-choice alcohol 
drinking affects sphingolipid homeostasis in the brain. We 
tested animals that had established stable 16 vol% alcohol 
consumption and underwent three withdrawal and rein-
statement periods, which had boosted consumption, for 
the abundance of SM species in the nucleus accumbens 
(Nac) and dorsal hippocampus (DH). Solarix XR (Bruker 
Daltonik GmbH) FT- MALDI Imaging mass spectrometric 
measurements in brain slices revealed significantly attenu-
ated levels of the three most abundant neuropil SM spe-
cies, SM 18:1 18:0, SM 18:1 18:1, and SM 18:1 20:0, in 
tgASM mice in the Nac (Fig. 5; Suppl. Figure 6, 7), which 
most likely results from enhanced ASM-mediated turnover 
to Cer as suggested above. Alcohol drinking significantly 
reduced the abundance of all three SM species in the Nac 
in WT mice. Interestingly, the alcohol effects were reversed 
in tgASM mice in the Nac, where drinking significantly 
enhanced SM levels. This is in line with the above reported 
alcohol inhibition of ASM activity, and thus the reduced 
turnover of SM species.
The same SM species were measured in the DH (Fig. 6; 
Suppl. Figure 8, 9). In this structure, ASM hyperactivity 
did not lead to altered SM abundance. Alcohol drinking 
reduced levels of all three SM species, but in the same way 
in WT and tgASM mice. Altogether, these findings suggest 
that ASM hyperactivity induces a sphingolipid allostasis in 
the Nac but not DH. Free-choice alcohol drinking partially 
restores sphingolipid homeostasis in a brain region-selec-
tive way.
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Fig. 4  Forced alcohol exposure by repeated injection (2 g/kg; 
i.p.) has no anti-depressant effects on depression-like behavior in 
depressed mice, but non-specifically reduces anxiety. The error bars 
show the mean ± SEM. a Forced alcohol exposure has no effect on 
mice over-expressing acid sphingomyelinase (tgASM, n = 14–15/
group) or wild type (WT, n = 12–13/group) mice in the novelty sup-
pressed feeding test (p > 0.05). b Forced alcohol exposure enhances 
depression-like behavior in the forced swim test non-selectively in 
tgASM (t = −1.931, p = 0.031) as well as WT mice (t = −2.388, 
p = 0.012). c, d No effect of forced alcohol exposure in the open field 
test in tgASM as well as WT mice (p > 0.05) in first 5 min of testing 
(p > 0.05) was seen. e–g In the elevated plus maze test for anxiety, 
forced alcohol exposure reduced anxiety-like behavior non-selec-
tively in tgASM as well as WT mice, which is shown by enhanced 
open arm time (tgASM: t = −2.277, p = 0.015; WT: t = −2.216, 
p = 0.018) and an increase in the number of open arm entries 
(tgASM: t = −2.521, p = 0.009; WT: t = −2.380, p = 0.012), but 
no significant effect on the latency to enter open arms (p > 0.05) was 
seen. h The ASM activity in plasma was enhanced in tgASM mice 
(n = 12–15/group) compared to WT (n = 13–14/group; t = −6.072, 
p < 0.001). Forced alcohol exposure had no effect on ASM activity in 
tgASM mice (p > 0.05) (*p < 0.05, **p < 0.01; ***p < 0.001)
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Alcohol drinking restores monoamine levels in tgASM 
mice
Depression is frequently associated with a disturbance of 
monoaminergic homeostasis in the brain [8, 39]. Here, we 
inquired as to how ASM hyperactivity would change mon-
oamine homeostasis and whether alcohol drinking could 
reverse this. We established a stable consumption of water 
or 16 vol% alcohol in a free-choice alcohol drinking para-
digm. After 12 days of stable drinking animals were sacri-
ficed, and the tissue levels of serotonin (5-HT), dopamine 
(DA), and noradrenaline (NA) were measured in the ventral 
striatum (VS), DH and prefrontal cortex (PFC). In tgASM 
mice, we found a significant reduction in tissue 5-HT lev-
els in the VS, DH, and PFC compared to WT (Fig. 7a–c). 
Alcohol drinking reversed this effect, and thus re-estab-
lished 5-HT homeostasis in the VS and DH, but not in the 
PFC. ASM hyperactivity significantly reduced DA tissue 
levels in the DH but not in the VS or PFC (Fig. 7d–f). In 
the DH, alcohol drinking re-established DA homeostasis 
but had no effect on DA levels in the VS and PFC. NA tis-
sue levels did not appear to be under the control of ASM 
in all the brain structures investigated (Fig. 7g–i). Never-
theless, alcohol drinking significantly enhanced NA tissue 
levels selectively in tgASM but not in WT mice in all three 
brain areas. Altogether, these findings show that alcohol 
drinking restored 5-HT- and DA tissue homeostasis only in 
animals with ASM hyperfunction, which may contribute to 
the anti-depressant effects.
Alcohol and gene expression profiles in tgASM mice
Monoamine and sphingolipid homeostasis are both con-
trolled by the activity of numerous proteins in the brain. 
To map the downstream effects of ASM hyperactivity and 
alcohol drinking, we tested animals that had established a 
stable 16 vol% alcohol consumption and underwent three 
withdrawal and reinstatement periods for gene expression 
in the DH using RNA-seq (tgASM-alcohol: n = 6; WT-
alcohol: n = 5; tgASM-water: n = 3; WT-water: n = 4). 
The network analysis permits the identification of groups 
of genes (modules) with similar expression patterns across 
samples, which reflects shared biological functions and 
key functional pathways, as well as key hub genes within 
the module. From a total of 25,028 genes in the PFC, the 
network analysis identified a large number of modules 
(n = 88) with sizes ranging from 31 genes to 3378 genes 
(Fig. 8a). In this manner, the network analysis reduced 
thousands of genes across four conditions to a relatively 
small number of coherent gene modules that represent dis-
tinct transcriptional responses to either the overexpression 
in the murine ASM locus or alcohol treatment. We tested 
whether the expression of each module (summarized by its 
first principal component, the module eigengene) was asso-
ciated with a genotype (tgASM vs. WT) or treatment (alco-
hol vs. water) or genotype × treatment interaction using an 
ANOVA model. We identified one module each for geno-
type (M1) and treatment (M2) that passed a false discover 
rate (FDR) threshold of 5% (Suppl. Tab. 2, 3). None of the 
interaction modules satisfied this criterion.
The module with strongest association with the geno-
type consisted of 78 genes and showed an increased 
eigengene profile in tgASM (Fig. 8b). The gene ontol-
ogy (GO) enrichment analysis showed that genes related 
to regulation of pH (Slc9a4, Slc9a2, and Slc26a4), ion 
transmembrane transport (Grik4, Kctd18, Slc9a4, Gabra5, 
Pkd1l3, and Slc26a4), behavioral fear responses (Npy2r 
and Gabra5), neuroprotection (Gabra5 and Trim2) and 
a neuropeptide signaling pathway (Npy2r and Pkd1l3) 
were significantly enriched in this module (Fig. 8b; Suppl. 
Tab. 2). In addition, several canonical pathways were sig-
nificantly enriched in this module including neuroactive 
Fig. 5  Free-choice alcohol drinking re-establishes sphingomyelin 
homeostasis in the nucleus accumbens (Nac) of mice over-expressing 
acid sphingomyelinase (tgASM). The mass spectrum generated in a 
MALDI-MS imaging contains hundreds of ion signals associated 
with each individual pixel. The MALDI images were acquired with 
x–y-raster widths of 30 µm for coronal sections. Slice MALDI mass 
spectrograms for the three most abundant sphingomyelin (SM) spe-
cies in the neuropil of the Nac of water or 16 vol% alcohol (EtOH) 
drinking tgASM or wild type (WT) mice with regular consumption 
and three withdrawal and reinstatement episodes. The Nac was ana-
lyzed as a target area of interest. The error bars show a mean of nine 
samples/genotype-treatment (±SEM) for four animals. The data are 
shown using a rainbow scale, normalized against the total ion count. 
a The coronal tissue sections show SM 18:1 18:0 highly enriched 
in the Nac. b The abundance of SM 18:1 18:0 is largely reduced in 
tgASM mice (ANOVA, factor genotype: F1,32 = 240.793, p < 0.001). 
Alcohol drinking reduces levels of SM 18:1 18:0 in WT mice, but 
enhances it in tgASM mice (ANOVA, genotype × treatment interac-
tion: F1,32 = 196.600, p < 0.001). c The coronal tissue sections show 
SM 18:1 18:1 that is highly enriched in the Nac and piriform cortex. 
d The abundance of SM 18:1 18:1 is largely reduced in tgASM mice 
(ANOVA, factor genotype: F1,32 = 165.064, p < 0.001). Alcohol 
drinking reduces levels of SM 18:1 18:1 in WT mice but enhances 
it in tgASM mice (ANOVA, genotype × treatment interaction: 
F1,32 = 161.448, p < 0.001). e The coronal tissue sections show SM 
18:1 20:0 that is highly enriched in the somatosensory and motor cor-
tex and in dorsolateral striatum. f The abundance of SM 18:1 20:0 is 
reduced in tgASM mice (ANOVA, factor genotype: F1,32 = 174.123, 
p < 0.001). Alcohol drinking reduces levels of SM 18:1 20:0 in 
WT mice but enhances it in tgASM mice (ANOVA, factor treat-
ment: F1,32 = 7.292, p < 0.011; genotype × treatment interaction: 
F1,32 = 163.235, p < 0.001). g Mass spectrogram for a single slice 
at the Nac level with SM target masses. h Anatomical analysis of the 
slice at the level of the Nac (ac commisura anterior, CiC cingular cor-
tex, CoCa corpus callosum, CPu caudate putamen, DB diagonal band 
of Broca, lv ventricle, InC insular cortex, MoC motor cortex, Nac/c 
Nac core, Nac/s Nac shell, PiC piriform cortex, SoSeC somatosen-
sory cortex). For an overview on white matter and the liquor associ-
ated SM species, see Suppl. Figure 6, 7 (***p < 0.001; #p < 0.001 vs. 
WT-water)
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ligand-receptor interactions, metabolic pathways, and 
endocytosis (Suppl. Tab. 2). Interestingly, all genes in the 
module are up-regulated in tgASM when compared to WT 
mice and the top differentially expressed genes included 
the glutamate-gated ionic channel family gene, Grik4 (log2 
Fold Change, FC = 0.3, p = 5.10 × 10−06); the intracel-
lular pH regulator, Slc9a4 (FC = 0.83, p = 1.28 × 10−05); 
the guanine nucleotide exchange factor, Dock9 (FC = 0.22, 
p = 1.69 × 10−05); the gene encoding glycoprotein, Nell2 
(FC = 0.22, p = 4.31 × 10−05); and the gene involved in 
central nervous system development, Hapln1 (FC = 0.31 
p = 1.54 × 10−04). Grik4 encodes the kainic acid-type glu-
tamate receptor 1 (KA1) subunit, which co-assembles with 
other glutamate receptor subunits to form cation-selective 
ion channels but may also possess metabotropic functions. 
Interestingly, human genetic studies have shown that vari-
ants in this gene were associated with major depressive dis-
order and alcoholism.
The module M2, the most significantly associated mod-
ule with alcohol consumption, is comprised of 50 genes 
and showed an increased eigengene profile in active drinker 
(AD) mice compared to mice treated with water (Fig. 8c). 
The M2 is significantly enriched with genes involved 
in spermatogenesis (Catsperg2, Ovol1, and Tbpl1), cell 
adhesion (Cdh7, Cass4, and Cdh4), cell proliferation 
(Srrt and Tyr), and multicellular organismal development 
(Catsperg2, Gap43, Utp3, and Fam3c) (Suppl. Tab. 3). Sev-
eral hub genes in this module showed a strong differential 
expression between AD and water-treated mice, including 
the calcium dependent cell–cell adhesion molecule, Cdh7 
(FC = 0.44, p = 7.28 × 10−04); a member of a family 
with sequence similarity 3 (FAM3), Fam3c (FC = 0.23, 
p = 3.5 × 10−03); and a gene encoding a protein that 
promotes adhesion between dendrites and axons, Nxph1 
(FC = 0.23, p = 4.75 × 10−03). Interestingly, genome-wide 
association studies in humans demonstrated that common 
variants in Cdh7 were associated with bipolar disorder and 
major depressive disorder (MDD), indicating the comor-
bidity of MDD and alcohol. Altogether this analysis does 
not suggest a direct ASM regulation of cell membrane 
properties by controlling sphingolipid pathways. It rather 
suggests a regulation of cell homeostasis by controlling 
properties, such as pH, ion transmembrane transport, and 
neuroprotection-related genes. ASM hyperactivity leads to 
an over-expression of anxiety-related genes coding for the 
neuropeptide Y receptor Y2 (NPY-RY2) and gamma-amin-
obutyric acid A receptor, subunit alpha 5 (α5-GABAA-R). 
Neuropeptide Y (NPY) may exert potent anxiolytic effects 
through Y1 receptors but augments anxiety through Y2 
receptors [71]. An enhanced α5-GABAA-R function was 
shown to be associated with anxiety in animals [7] and 
humans [26]. Both genes may, therefore, be additional 
mechanisms of the depressogenic effects of ASM hyperac-
tivity [21].
No evidence for the involvement of oxidative stress 
in alcohol’s antidepressant effects
While the ‘‘housekeeping’’ function of ASM in perma-
nent SM turnover has been known for a long time, more 
recent results have defined the role of ASM in the cellular 
response to oxidative stress [31]. The activation of ASM, 
following psychosocial stress-triggered oxidative stress 
results in the generation of Cer [38]. Depression is associ-
ated with oxidative stress at the cellular level [45], which 
may in turn further enhance ASM activity. Antidepressant 
action may be at least partially mediated through a reduc-
tion of oxidative stress in the brain [67]. To investigate 
oxidative stress in tgASM mice and its potential reversal 
by alcohol, we measured the superoxide dismutase activ-
ity (SOD) of animals with established consumption of 
16 vol% alcohol drinking immediately after drinking ces-
sation and after one week of abstinence. Alcohol drinking 
did not affect SOD activity in the cerebellum of the WT or 
tgASM mice after drinking. Only after 7 days of abstinence 
from drinking there was an increase in tgASM mice (Suppl. 
Figure 10). These findings suggest that oxidative stress 
plays no role in ASM-induced depression and its reversal 
by alcohol drinking.
Fig. 6  Free-choice alcohol drinking reduces sphingomyelin levels in 
the dorsal hippocampus (DH) of mice over-expressing acid sphingo-
myelinase (tgASM). The MALDI images were acquired with x–y-ras-
ter widths of 30 µm for coronal sections. Slice MALDI mass spec-
trograms for the three most abundant sphingomyelin (SM) species in 
the neuropil of the DH of water or 16 vol% alcohol (EtOH) drinking 
tgASM or wild type (WT) mice with regular consumption and three 
withdrawal and reinstatement episodes. The DH was analyzed as a 
target area of interest. The errorbars show the mean of eight samples/
genotype–treatment (±SEM) for four animals. The data are shown 
using a rainbow scale that is normalized against the total ion count. a 
The coronal tissue sections show that SM 18:1 18:0 is enriched in the 
hypothalamus, amygdala, and DH. b The abundance of SM 18:1 18:0 
was not changed in tgASM mice (p > 0.05). Alcohol drinking reduces 
levels of SM 18:1 18:0 in WT and tgASM mice to the same degree 
(ANOVA, factor treatment: F1,28 = 63.281, p < 0.001). c The coro-
nal tissue sections show that SM 18:1 18:1 is particularly enriched in 
the amygdala and hypothalamus. d The abundance of SM 18:1 18:1 
was not changed in tgASM mice (p > 0.05). Alcohol drinking reduces 
levels of SM 18:1 18:1 in WT and tgASM mice to the same degree 
(ANOVA, factor treatment: F1,28 = 80.920, p < 0.001). e The coronal 
tissue sections show SM 18:1 20:0 enriched in the thalamus and ven-
tricles. f The abundance of SM 18:1 20:0 was not changed in tgASM 
mice (p > 0.05). Alcohol drinking reduces levels of SM 18:1 20:0 in 
WT and tgASM mice to the same degree (ANOVA, factor treatment: 
F1,28 = 36.964, p < 0.001). g Mass spectrogram for a single slice 
point at the DH level with SM target masses. h Anatomical analysis 
of the slice at level of the Nac (Amyg amygdala, cc corpus callosum, 
ci commisura interior, Ctx cortex, dHipp dorsal hippocampus, Hyp 
hypothalamus, Thal thalamus). For an overview on white matter and 
liquor associated SM species, see Suppl. Figure 8, 9 (***p < 0.001)
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Discussion
Neurobiological models of alcoholism assume that the 
direct positive and negative reinforcing action of alcohol 
maintains consumption, which is mediated by changes 
in the protein function of the brain [25, 35, 68]. This, so 
far, has neither led to effective prevention nor treatment of 
AUD. This may also not explain paradoxical action, such 
as anti-depressive effects. The expansion of the scope 
towards a systemic understanding may thus offer new 
approaches. Here, we show the first mechanism, to our 
knowledge, of effective alcohol instrumentalization, which 
is based on ASM action in the brain and an alcohol-induced 
re-establishment of sphingolipid homeostasis. We found 
that mice in which ASM hyperactivity caused a depressive 
phenotype drink significantly more alcohol than the WT 
controls. Alcohol drinking is also more susceptible to with-
drawal effects. Alcohol conditioned reinforcing and loco-
motor effects are established faster in these mice, while the 
sedative effects are not affected. Thus, the anti-depressive 
effects of alcohol may not result from a sedating action. 
Mice with ASM hypoactivity showed slightly diminished 
alcohol consumption and a lack of alcohol’s conditioned 
reinforcing and locomotor sensitizing effects. This suggests 
that ASM controls alcohol consumption and alcohol rein-
forcement in both directions in parallel to emotional behav-
ior [21]. Interestingly, free-choice alcohol consumption, 
which allows for self-titration, normalizes ASM activity 
in the brain and selectively reduces depression-like behav-
ior in depressed tgASM mice. Forced alcohol exposure, in 
contrast, had no effect on brain ASM activity and instead 
enhanced depression-like behavior in tgASM and WT mice 
alike. It has to be admitted that due to the individual choice 
of the amount of alcohol consumed and the specific time of 
consumption, free-choice alcohol drinking cannot exactly 
be mimicked by forced alcohol exposure, where a medium 
dose of alcohol was given at a fixed time to each animal. 
However, both methods of alcohol exposure had been 
shown to have positive reinforcing action in mice, either in 
conditioned place preference [12] or by maintaining con-
sumption behavior [11].
There is a well-known correlative link between the anxi-
ety and depression traits of an organism and its respon-
siveness to alcohol [3, 23]. Numerous studies have shown 
that forced exposure, e.g., by injection, as well as the free-
choice consumption of alcohol can have acute anxiolytic 
and antidepressant effects, which may last up to 24 h [4, 
74]. The effects of forced exposure, however, wear off 
with repeated exposure. This reversal was suggested to be 
based on a switch from excitatory to the inhibitory action 
of alcohol on mesocortico-limbic monoamine responses 
after chronic exposure [33, 50]. We found mild anxio-
lytic effects in WT mice after several weeks of free-choice 
alcohol consumption and strong anxiolytic effects after 
acute alcohol injection in the EPM test. Since the EPM 
was tested after only two injections in a series of five sub-
chronic alcohol injections, this may account for the rather 
acute effects of the test. Chronic alcohol exposure during 
free drinking did not affect depression-like behavior in sev-
eral tests. However, repeated alcohol injections increased 
depression-like behavior in WT and tgASM mice in the 
FST. At the time of the testing the animals had received a 
total of five alcohol injections in the forced exposure treat-
ment. Following this, our findings confirm the previous 
data on the rather complex time course in the emotional 
effects of acute and chronic forced alcohol exposure. In 
this study, free-choice alcohol consumption—but not sub-
chronic forced exposure—reduced depression-like behav-
ior in depressed tgASM mice. The selective anti-depressive 
effects of chronic free-choice alcohol consumption have 
also been reported in animals with a high susceptibility 
to chronic mild stress which was related to an opioidergic 
mechanism [62]. Overall, the present studies suggest that 
the anti-depressant effects of alcohol do not only depend 
on its pharmacological action but also on the emotional 
state of the organism and the free-access and self-titration 
opportunity.
In WT mice, free-choice alcohol drinking reduced 
the tissue levels of the most abundant SM species in the 
Nac and DH of mice. This is in line with the reduction 
of plasma SM species in alcohol dependent patients [60]. 
Previous studies also reported a corresponding decrease in 
Fig. 7  Free-choice alcohol drinking re-establishes monoamine tis-
sue homeostasis in the ventral striatum (VS) and dorsal hippocam-
pus (DH) of mice over-expressing acid sphingomyelinase (tgASM; 
n = 14–15/group). The error bars show the mean ± SEM. of mono-
amine concentrations in the wet tissue of water or 16 vol% alcohol 
drinking tgASM or wild type (WT, n = 14–16/group) mice. a–c The 
serotonin (5-HT) tissue levels are reduced in tgASM mice in the VS, 
DH, and prefrontal cortex PFC. Alcohol drinking reduces 5-HT lev-
els in the DH and as a trend in the VS but has no effect in the PFC 
in WT mice. In contrast, in tgASM mice, alcohol drinking enhances 
5-HT levels in the VS (ANOVA, genotype × treatment interaction: 
F1,56 = 8.627, p = 0.005) and in the DH (ANOVA, genotype × treat-
ment interaction: F1,55 = 9.590, p = 0.003) but had no effect in 
the PFC (ANOVA, factor genotype: F1,58 = 8.170, p = 0.006). d–f 
The dopamine (DA) tissue levels are reduced in tgASM mice in the 
DH but not in the VS or PFC. Alcohol drinking reduces DA levels 
in the DH in WT mice. In contrast, in tgASM mice, alcohol drink-
ing enhances DA levels in the DH (ANOVA, genotype × treat-
ment interaction: F1,54 = 7.616, p = 0.008) but had no effect in 
the VS or PFC (p > 0.05). g–i Noradrenaline (NA) tissue levels are 
not affected by ASM over-expression in any of the brain structures 
investigated. Alcohol drinking had no effect on NA levels in WT 
mice but enhanced NA levels in tgASM mice in the VS, DH, and 
PFC, as shown by pre-planned comparisons (*p < 0.05, **p < 0.01; 
***p < 0.001)
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Cer species in the cortex and forebrain after alcohol binge 
drinking in mice [2] and rats [18], that was not mediated 
by the altered activity of ASM but by reduced activity of 
sphingolipid delta(4)-desaturase, an enzyme involved in 
Cer de novo synthesis [18]. In mice with ASM hyperactiv-
ity that show already attenuated levels of these SM species, 
Fig. 8  Acid sphingomyelinase 
(ASM) controls gene co-expres-
sion in the dorsal hippocampus 
(DH) of mice, a brain region 
that is essentially related to the 
ASM control of depression- and 
extinction-related behavior 
[21, 29]. a The co-expression 
network of ASM and alcohol. A 
cluster dendrogram generated 
by hierarchical clustering of 
genes on the basis of topo-
logical overlap. The modules of 
correlated genes were assigned 
colors and are indicated by 
the horizontal bar beneath the 
dendrogram, where all unas-
signed genes were placed in the 
gray module. b The functional 
enrichment analyses of the 
module associated with geno-
type status. The boxplots com-
pare the module eigenvalues 
of transgenic ASM (TG) and 
wild-type (WT) genotype status. 
For genotype status compari-
sons, the p values are calculated 
using the full ANOVA model. 
The results of the functional 
enrichment analyses (BP: gene 
ontology biological process) 
for this module are represented 
in the bar plots. We used the 
hypergeometric test to calculate 
the p values and used the false 
discovery rate (FDR) of 5% to 
obtain significantly enriched BP 
terms. c The functional enrich-
ment analyses of the module 
associated with treatment condi-
tions. The boxplots compare 
the module eigenvalues of the 
active drinker (AD) and water- 
(WA) treated mice, and the p 
values are calculated using the 
full ANOVA model. The results 
of the functional enrichment 
analyses for this module are 
represented in the bar plots
a
b
c
Modules
P = 4.4 x 10-4
P = 3.9 x 10-4
tgASM  WT
EtOH  water
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alcohol drinking had the opposite effect and partially 
reversed the SM decline, thus re-establishing SM homeo-
stasis. These findings are in line with a previous observa-
tion that a functional inhibition of the ASM would yield an 
antidepressant effect [21, 38]. Interestingly, this effect was 
brain-region specific and did not occur in the DH. These 
findings further support the notion of a brain-region spe-
cific fine tuning of sphingolipid activity during behavioral 
adaptations and their emotional correlates [29, 53].
Depression is associated with the dysregulation of mon-
oaminergic activity [8, 39]. Here, we show that depression 
induced by ASM hyperactivity coincides with reduced tis-
sue levels of 5-HT and DA, but not NA, in several brain 
structures. 5-HT and DA deficits are partially reversed by 
alcohol drinking in depressed mice, with no effect in WT 
mice. These findings suggest that re-establishing sphin-
golipid homeostasis has downstream effects and also nor-
malizes the 5-HT and DA function preferentially in the VS 
and DH.
An interesting observation was the region specific effect 
of free-choice alcohol drinking on sphingolipid allosta-
sis. This study reported three different types of sphin-
golipid expressions in the brain: (1) gray matter-associated 
(Figs. 5, 6), (2) white matter-associated (Suppl. Figure 6 
and 8), and (3) liquor-associated (Suppl. Figure 7 and 9) 
SM species. Among the gray matter-associated sphingolip-
ids, there was a brain region specific distribution of SM 
and Cer species [2, 29], which is mediated by local sphin-
golipid catabolizing enzymes, such as ASM [29]. This 
may also suggests, that sphingolipid homeostasis is regu-
lated at the local tissue level. The Nac is compared to, e.g., 
the DH, a brain region with strong monoaminergic inner-
vation (e.g., Fig. 7). In light of the observed link between 
ASM activity and monoamine tissue levels and the well-
known effect of alcohol on dopamine [68] and serotonin 
[50] activity in the Nac, the Nac may appear to be a brain 
region that is exclusively sensitive to a sphingolipid-dopa-
mine/serotonin interaction, and thus the alcohol effects on 
sphingolipid allostasis.
A limitation of this study is that the present model of 
a sphingolipid-driven depression does not account for all 
types of depression observed. Depression is a heterogene-
ous disorder with numerous genetic and environmental 
risk factors leading to distinct pathways and rather unique 
behavioral and somatic symptoms [38, 39]. Therefore, the 
suggested mechanism of depression-induced alcohol abuse 
may only apply to a subpopulation of depressed patients, 
characterized by high innate or induced ASM activity [36]. 
For these patients, the present findings may offer a new tar-
get for diagnostic and individualized treatment. Whether 
other pathogenic pathways into a depression use a simi-
lar pathway to induce alcohol abuse behavior needs to be 
addressed in future studies.
Notably, alcohol is not a treatment for depression and, 
given its neurotoxic action and neuropathological effects at 
higher doses, it should never be one. However, the clinical 
reality in the western world, where approximately 30% of 
depressed patients with co-morbid AUD engage in alcohol 
consumption to self-medicate for their depression, should 
not be denied. Therefore, our findings do not suggest alco-
hol as a new treatment for depression but focus on what 
alcohol does in these patients: it normalizes a lipid imbal-
ance in the brain. Herein, the present findings suggest a new 
class of molecules (i.e., the sphingolipids) and pathways 
(their controlling enzyme cascades) for the understanding 
and treatment of affective disorders-AUD comorbidity.
We propose that alcohol drinking can have paradoxi-
cal antidepressant effects in depressed organisms. This 
is mediated by an alcohol-induced restoration of ASM 
activity and subsequently of sphingolipid- and monoam-
ine homeostasis. This may provide the first mechanism for 
alcohol instrumentalization with the goal to self-medicate 
for depressive symptoms.
Acknowledgements We thank Benedikt Quinger and Juliana Monti 
for their technical assistance. L.S. Kalinichenko received a PhD 
thesis scholarship by the IZKF, Erlangen, and the present work was 
conducted in fulfilment of the requirements to obtain the degree “Dr. 
hum. biol.”. J. Tiesel received an MD thesis scholarship from the 
IZKF, Erlangen. The present work was performed in fulfilment of the 
requirements for obtaining the degree “Dr. med.” for J.T and E.S. This 
work was supported by funding from DFG Grants KO 947/15-1, KO 
947/13-1 (J.K.), GU 335/29-1 (E.G.) and MU 2789/8-1 (C.P.M.) and 
by funding from the Interdisciplinary Center for Clinical Research 
(IZKF) Erlangen, Project E13 (C.P.M., M.R., J.K.). The funders had 
no role in the study design, data collection and analysis, decision to 
publish, or preparation of the manuscript.
Compliance with ethical standards 
Conflict of interest The authors declare no competing financial inter-
ests.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution 4.0 International License (http://crea-
tivecommons.org/licenses/by/4.0/), which permits unrestricted use, 
distribution, and reproduction in any medium, provided you give 
appropriate credit to the original author(s) and the source, provide a 
link to the Creative Commons license, and indicate if changes were 
made.
References
 1. Anders S, Pyl PT, Huber W (2015) HTSeq—a Python frame-
work to work with high-throughput sequencing data. Bioinfor-
matics 31:166–169
 2. Bae M, Bandaru VV, Patel N, Haughey NJ (2014) Ceramide 
metabolism analysis in a model of binge drinking reveals both 
neuroprotective and toxic effects of ethanol. J Neurochem 
131:645–654
482 Acta Neuropathol (2017) 133:463–483
1 3
 3. Bahi A (2013) Individual differences in elevated plus-maze 
exploration predicted higher ethanol consumption and prefer-
ence in outbred mice. Pharmacol Biochem Behav 105:83–88
 4. Barkley-Levenson AM, Crabbe JC (2015) Genotypic and sex dif-
ferences in anxiety-like behavior and alcohol-induced anxiolysis 
in High Drinking in the Dark selected mice. Alcohol 49:29–36
 5. Baum-Baicker C (1985) The psychological benefits of moderate 
alcohol consumption: a review of the literature. Drug Alcohol 
Depend 15:305–322
 6. Boden JM, Fergusson DM (2011) Alcohol and depression. 
Addiction 106:906–914
 7. Botta P, Demmou L, Kasugai Y, Markovic M, Xu C, Fadok JP 
et al (2015) Regulating anxiety with extrasynaptic inhibition. Nat 
Neurosci 18:1493–1500
 8. Carr GV, Lucki I (2010) The Role of Serotonin in Depression. 
In: Müller CP, Jacobs BL (eds) Handbook of the behavioral neu-
robiology of serotonin. Academic Press, London, pp 493–506
 9. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S 
et al (2013) STAR: ultrafast universal RNA-seq aligner. Bioin-
formatics 29:15–21
 10. Easton AC, Lucchesi W, Schumann G, Peter GK, Müller CP, 
Fernandes C (2011) alphaCaMKII autophosphorylation controls 
exploratory activity to threatening novel stimuli. Neuropharma-
cology 61:1424–1431
 11. Easton AC, Lucchesi W, Lourdusamy A, Lenz B, Solati J, Golub 
Y et al (2013) αCaMKII autophosphorylation controls the estab-
lishment of alcohol drinking behavior. Neuropsychopharmacol-
ogy 38:1636–1647
 12. Easton AC, Lucchesi W, Mizuno K, Fernandes C, Schumann G, 
Giese KP et al (2013) alphaCaMKII autophosphorylation con-
trols the establishment of alcohol-induced conditioned place 
preference in mice. Behav Brain Res 252:72–76
 13. EMCDDA (2012) European Monitoring Center for Addictive 
Drugs, State of the drug problem 2012. http://www.emcdda.europa.
eu/publications/annual-report/2012. Accessed 20 June 2013
 14. Fantini J, Barrantes FJ (2009) Sphingolipid/cholesterol regula-
tion of neurotransmitter receptor conformation and function. 
Biochim Biophys Acta 1788:2345–2361
 15. Franklin KBJ, Paxionos G (1997) The mouse brain in stereotaxic 
coordinates. Academic Press, San Diego
 16. Garcia-Valdecasas-Campelo E, Gonzalez-Reimers E, Santolaria-
Fernandez F, De La Vega-Prieto MJ, Milena-Abril A, Sanchez-
Perez MJ et al (2007) Brain atrophy in alcoholics: relationship 
with alcohol intake; liver disease; nutritional status, and inflam-
mation. Alcohol Alcohol 42:533–538
 17. Gilpin NW, Koob GF (2008) Neurobiology of alcohol depend-
ence: focus on motivational mechanisms. Alcohol Res Health 
31:185–195
 18. Godfrey J, Jeanguenin L, Castro N, Olney JJ, Dudley J, Pipkin 
J et al (2015) Chronic voluntary ethanol consumption induces 
favorable ceramide profiles in selectively bred alcohol-preferring 
(P) rats. PLoS One 10:e0139012
 19. Grant BF, Harford TC (1995) Comorbidity between DSM-IV 
alcohol use disorders and major depression: results of a national 
survey. Drug Alcohol Depend 39:197–206
 20. Gulbins E, Kolesnick R (2003) Raft ceramide in molecular med-
icine. Oncogene 22:7070–7077
 21. Gulbins E, Palmada M, Reichel M, Lüth A, Böhmer C, Amato 
D et al (2013) Acid sphingomyelinase-ceramide system mediates 
effects of antidepressant drugs. Nature Med 19:934–938
 22. Hannun YA, Obeid LM (2008) Principles of bioactive lipid sig-
nalling: lessons from sphingolipids. Nature Rev Mol Cell Biol 
9:139–150
 23. Hayton SJ, Mahoney MK, Olmstead MC (2012) Behavioral 
traits predicting alcohol drinking in outbred rats: an investigation 
of anxiety, novelty seeking, and cognitive flexibility. Alcohol 
Clin Exp Res 36:594–603
 24. Heath DB (2000) Drinking occasions: comparative perspectives 
on alcohol and culture. Brunner/Mazel, Levittown
 25. Heilig M, Koob GF (2007) A key role for corticotropin-
releasing factor in alcohol dependence. Trends Neurosci 
30:399–406
 26. Hodges LM, Fyer AJ, Weissman MM, Logue MW, Haghighi F, 
Evgrafov O et al (2014) Evidence for linkage and association of 
GABRB3 and GABRA5 to panic disorder. Neuropsychopharma-
cology 39(10):2423–2431
 27. Horinouchi K, Erlich S, Perl DP, Ferlinz K, Bisgaier CL, Sand-
hoff K et al (1995) Acid sphingomyelinase deficient mice: a 
model of types A and B Niemann–Pick disease. Nature Genet 
10:288–293
 28. Huston JP, Silva MA, Topic B, Müller CP (2013) What’s con-
ditioned in conditioned place preference? Trends Pharmacol Sci 
34:162–166
 29. Huston JP, Kornhuber J, Mühle C, Japtok L, Komorowski M, 
Mattern C et al (2016) A sphingolipid mechanism for behavioral 
extinction. J Neurochem 137:589–603
 30. Jain M, Ngoy S, Sheth SA, Swanson RA, Rhee EP, Liao R et al 
(2014) Systematic survey of lipids across mouse tissues. Am J 
Physiol Endocrinol Metab 306:E854–E868
 31. Jenkins RW, Canals D, Hannun YA (2009) Roles and regulation 
of secretory and lysosomal acid sphingomyelinase. Cell Signal 
21:836–846
 32. Jung ME, Metzger DB (2016) A sex difference in oxidative 
stress and behavioral suppression induced by ethanol withdrawal 
in rats. Behav Brain Res 314:199–214
 33. Karkhanis AN, Huggins KN, Rose JH, Jones SR (2016) Switch 
from excitatory to inhibitory actions of ethanol on dopamine lev-
els after chronic exposure: role of kappa opioid receptors. Neu-
ropharmacology 110:190–197
 34. Kippin TE (2011) Does drug mis-instrumentalization lead to 
drug abuse? Behav Brain Sci 34:316–317
 35. Koob GF, Le Moal M (2008) Addiction and the brain antireward 
system. Annu Rev Psychol 59:29–53
 36. Kornhuber J, Medlin A, Bleich S, Jendrossek V, Henkel AW, 
Wiltfang J et al (2005) High activity of acid sphingomyelinase in 
major depression. J Neural Transm 112:1583–1590
 37. Kornhuber J, Tripal P, Reichel M, Mühle C, Rhein C, Mue-
hlbacher M et al (2010) Functional Inhibitors of Acid Sphin-
gomyelinase (FIASMAs): a novel pharmacological group of 
drugs with broad clinical applications. Cell Physiol Biochem 
26:9–20
 38. Kornhuber J, Müller CP, Becker KA, Reichel M, Gulbins E 
(2014) The ceramide system as a novel antidepressant target. 
Trends Pharmacol Sci 35:293–304
 39. Krishnan V, Nestler EJ (2008) The molecular neurobiology of 
depression. Nature 455:894–902
 40. Ledesma MD, Prinetti A, Sonnino S, Schuchman EH (2011) 
Brain pathology in Niemann Pick disease type A: insights 
from the acid sphingomyelinase knockout mice. J Neurochem 
116:779–788
 41. Lee KM, Coehlo M, McGregor HA, Waltermire RS, Szumlin-
ski KK (2015) Binge alcohol drinking elicits persistent negative 
affect in mice. Behav Brain Res 291:385–398
 42. Lenz B, Müller CP, Stoessel C, Sperling W, Biermann T, 
Hillemacher T et al (2012) Sex hormone activity in alcohol 
addiction: integrating organizational and activational effects. 
Prog Neurobiol 96:136–163
 43. Love MI, Huber W, Anders S (2014) Moderated estimation of 
fold change and dispersion for RNA-seq data with DESeq2. 
Genome Biol 15:550
483Acta Neuropathol (2017) 133:463–483 
1 3
 44. Lovinger DM, Crabbe JC (2005) Laboratory models of alcohol-
ism: treatment target identification and insight into mechanisms. 
Nat Neurosci 8:1471–1480
 45. Michel TM, Frangou S, Thiemeyer D, Camara S, Jecel J, Nara K 
et al (2007) Evidence for oxidative stress in the frontal cortex in 
patients with recurrent depressive disorder—a postmortem study. 
Psychiatry Res 151:145–150
 46. Miquel M, Vazquez-Sanroman D, Carbo-Gas M, Gil-Miravet I, 
Sanchis-Segura C, Carulli D et al (2016) Have we been ignoring 
the elephant in the room? Seven arguments for considering the 
cerebellum as part of addiction circuitry. Neurosci Biobehav Rev 
60:1–11
 47. Müller CP, Schumann G (2011) Drugs as instruments: a new 
framework for non-addictive psychoactive drug use. Behav Brain 
Sci 34:293–310
 48. Müller CP, Schumann G (2011) To use or not to use: expanding 
the view on non-addictive psychoactive drug consumption and 
its implications. Behav Brain Sci 34:328–347
 49. Müller CP (2013) Episodic memories and their relevance for 
psychoactive drug use and addiction. Front Behav Neurosci 7:34
 50. Müller CP, Homberg JR (2015) The role of serotonin in drug use 
and addiction. Behav Brain Res 277:146–192
 51. Müller CP, Reichel M, Mühle C, Rhein C, Gulbins E, Kornhuber 
J (2015) Brain membrane lipids in major depression and anxiety 
disorders. Biochim Biophys Acta 1851:1052–1065
 52. Nuber S, Harmuth F, Kohl Z, Adame A, Trejo M, Schönig K et al 
(2013) A progressive dopaminergic phenotype associated with 
neurotoxic conversion of α-synuclein in BAC-transgenic rats. 
Brain 136:412–432
 53. Oliveira TG, Chan RB, Bravo FV, Miranda A, Silva RR, Zhou 
B et al (2016) The impact of chronic stress on the rat brain lipi-
dome. Mol Psychiatry 21:80–88
 54. Peele S, Brodsky A (2000) Exploring psychological benefits 
associated with moderate alcohol use: a necessary corrective 
to assessments of drinking outcomes? Drug Alcohol Depend 
60:221–247
 55. Pettinati HM, O’Brien CP, Dundon WD (2013) Current status of 
co-occurring mood and substance use disorders: a new therapeu-
tic target. Am J Psychiatry 170:23–30
 56. Poklis A, Mackell MA (1982) Evaluation of a modified alcohol 
dehydrogenase assay for the determination of ethanol in blood. 
Clin Chem 28:2125–2127
 57. Pum ME, Carey RJ, Huston JP, Müller CP (2008) Role of medial 
prefrontal, entorhinal, and occipital 5-HT in cocaine-induced 
place preference and hyperlocomotion: evidence for multiple 
dissociations. Psychopharmacology 201:391–403
 58. Reichel M, Greiner E, Richter-Schmidinger T, Yedibela O, Tripal 
P, Jacobi A et al (2010) Increased acid sphingomyelinase activ-
ity in peripheral blood cells of acutely intoxicated patients with 
alcohol dependence. Alcohol Clin Exp Res 34:46–50
 59. Reichel M, Beck J, Mühle C, Rotter A, Bleich S, Gulbins E 
et al (2011) Activity of secretory sphingomyelinase is increased 
in plasma of alcohol-dependent patients. Alcohol Clin Exp Res 
35:1852–1859
 60. Reichel M, Honig S, Liebisch G, Luth A, Kleuser B, Gulbins 
E et al (2015) Alterations of plasma glycerophospholipid and 
sphingolipid species in male alcohol-dependent patients. Bio-
chim Biophys Acta 1851:1501–1510
 61. Robbins TW, Ersche KD, Everitt BJ (2008) Drug addiction and 
the memory systems of the brain. Ann N Y Acad Sci 1141:1–21
 62. Sacharczuk M, Juszczak G, Swiergiel AH, Jaszczak K, Lip-
kowski AW, Sadowski B (2009) Alcohol reverses depressive and 
pronociceptive effects of chronic stress in mice with enhanced 
activity of the opioid system. Acta Neurobiol Exp (Wars) 
69:459–468
 63. SAMHSA (2011) National survey on drug use and health, Sub-
stance Abuse and Mental Health Services Administration, 2011. 
Rockville http://www.samhsa.gov/data/NSDUH/ 011SummNat-
FindDetTables/Index.aspx). Accessed 20 June 2013
 64. Schuckit MA, Tipp JE, Bergman M, Reich W, Hesselbrock 
VM, Smith TL (1997) Comparison of induced and independent 
major depressive disorders in 2,945 alcoholics. Am J Psychiatry 
154:948–957
 65. Schwarz E, Prabakaran S, Whitfield P, Major H, Leweke FM, 
Koethe D et al (2008) High throughput lipidomic profiling of 
schizophrenia and bipolar disorder brain tissue reveals altera-
tions of free fatty acids, phosphatidylcholines, and ceramides. J 
Proteome Res 7:4266–4277
 66. Shariatgorji M, Nilsson A, Goodwin RJ, Kallback P, Schintu 
N, Zhang X et al (2014) Direct targeted quantitative molecular 
imaging of neurotransmitters in brain tissue sections. Neuron 
84:697–707
 67. Smaga I, Pomierny B, Krzyzanowska W, Pomierny-Chamiolo L, 
Miszkiel J, Niedzielska E et al (2012) N-acetylcysteine possesses 
antidepressant-like activity through reduction of oxidative stress: 
behavioral and biochemical analyses in rats. Prog Neuropsy-
chopharmacol Biol Psychiatry 39:280–287
 68. Spanagel R (2009) Alcoholism: a systems approach from molec-
ular physiology to addictive behavior. Physiol Rev 89:649–705
 69. Stacey D, Bilbao A, Maroteaux M, Jia T, Easton AC, Longueville 
S et al (2012) RASGRF2 regulates alcohol-induced reinforce-
ment by influencing mesolimbic dopamine neuron activity and 
dopamine release. Proc Natl Acad Sci USA 109:21128–21133
 70. Süß P, Kalinichenko L, Baum W, Reichel M, Kornhuber J, 
Loskarn S et al (2015) Hippocampal structure and function are 
maintained despite severe innate peripheral inflammation. Brain 
Behav Immun 49:156–170
 71. Tasan RO, Nguyen NK, Weger S, Sartori SB, Singewald N, Heil-
bronn R et al (2010) The central and basolateral amygdala are 
critical sites of neuropeptide Y/Y2 receptor-mediated regulation 
of anxiety and depression. J Neurosci 30:6282–6290
 72. Veiga MP, Goñi FM, Alonso A, Marsh D (2000) Mixed mem-
branes of sphingolipids and glycerolipids as studied by spin-
label ESR spectroscopy. A search for domain formation. Bio-
chemistry 39:9876–9883
 73. Vengeliene V, Bilbao A, Molander A, Spanagel R (2008) Neurop-
harmacology of alcohol addiction. Br J Pharmacol 154:299–315
 74. Wolfe SA, Workman ER, Heaney CF, Niere F, Namjoshi S, 
Cacheaux LP et al (2016) FMRP regulates an ethanol-dependent 
shift in GABABR function and expression with rapid antidepres-
sant properties. Nat Commun 7:12867
 75. Zheng F, Puppel A, Huber SE, Link AS, Eulenburg V, van 
Brederode JF et al (2016) Activin controls ethanol potentiation 
of Inhibitory syn aptic transmission through GABA receptors 
and concomitant behavioral sedation. Neuropsychopharmacol-
ogy 41:2024–2033
